Clinical trial

Pyridostigmine as Immunomodulator in People Living With HIV

NCT03312244

StatusSUSPENDED

Study typeINTERVENTIONAL

Start date2019-07-01

PhasePHASE2

Study timeline

Study start (actual)2019-07-01Date precision: day

Registry last updated2020-04-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-1-infectionunresolved

CD4+ T Lymphocytopeniaunresolved

Immune Deficiencyunresolved

Immuno-senescenceunresolved

Interventions

Pyridostigmine BromideDRUG · verified · RxNorm: pyridostigmine bromide

PlaceboDRUG

Sponsors & collaborators

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiranlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03312244 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.